Dennis Grimaud
Chief Executive Officer
Dennis Grimaud brings over 40 years of experience in the health care industry and 30 years of experience in biotechnology as an entrepreneur, senior executive and consultant. He is currently Founder and Chief Executive Officer of Reliability, Execution, Development (RED), a healthcare and biotechnology company providing science, business and management services. He was most recently Chairman, Chief Executive Officer and Founder of DIATHERIX Laboratories, Inc. a clinical laboratory that provides testing services to physicians and hospitals for the identification of infectious disease through proprietary multiplexing PCR technology. He was Chief Executive Officer of Genaco Biomedical Products, Inc. providing Molecular Differential Diagnostics through multiplexing technology in infectious disease and cancer. He was also Chairman and CEO of Premier Micronutrient Corporation, a disease management company providing risk-based, disease specific micronutrient protocols that are adjunctive to standard therapy. Dennis was Founder, Chairman and CEO of ScyTech, Inc. a company providing management and business services to life science related biotechnology and health care companies.
He also co-founded and was Chairman, President and CEO of Cytometry Associates, Inc., a specialized cancer testing facility providing clinical diagnostic testing services to physician specialists and biopharmaceutical services to the pharmaceutical industry in drug discovery and clinical trials. Prior to Cytometry Associates he served as Vice President and General Manager of the Center for Clinical Sciences, a centralized esoteric testing center for International Clinical Laboratories, Inc. He also held the positions of Vice President ICL East, responsible for turning around troubled operational divisions and Vice President of Sales and Marketing at ICL responsible for developing market strategy for cooperative agreements with hospitals. Prior to joining ICL he held two positions with National Medical Enterprises, Inc. as Administrator of Medical Diagnostics and Director of Laboratory Services in materials management providing consultation to over 150 hospitals and medical facilities nationwide.
Mr. Grimaud was a director of MedBioGene a publically traded biotechnology company in Vancouver, Canada. He served on the Board of Directors of Genaco Biomedical Products, Inc., and is a founding member and former director of the Nashville Health Care Council, Nashville, TN. He was also a founding member Chairman and President of the Tennessee Biotechnology Association from 1998-2004. He is an invited speaker to healthcare payers, hospital corporations, boards of directors and academic institutions related to executive management programs. He is an advisor to Oliver Wyman an international consulting firm.
